Literature DB >> 30391574

Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.

Ryosuke Imai1, Masafumi Ono2, Naoki Nishimura3, Koyu Suzuki4, Nobuyuki Komiyama2, Tomohide Tamura3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30391574     DOI： 10.1016/j.jtho.2018.10.156

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  T cell checkpoint regulators in the heart.

Authors:  Nir Grabie; Andrew H Lichtman; Robert Padera
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

2.  Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.

Authors:  Ranjan Pathak; Anjan Katel; Erminia Massarelli; Victoria M Villaflor; Virginia Sun; Ravi Salgia
Journal:  Oncologist       Date:  2021-08-25

3.  Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.

Authors:  Naoki Hamada; Ayaka Maeda; Kaoru Takase-Minegishi; Yohei Kirino; Yumiko Sugiyama; Ho Namkoong; Nobuyuki Horita; Ryusuke Yoshimi; Hideaki Nakajima
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

4.  PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review.

Authors:  Na Yin; Xiangliang Liu; Xiaojun Ye; Wei Song; Jin Lu; Xiao Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

Review 5.  Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.

Authors:  Emma Matzen; Lars Erik Bartels; Brian Løgstrup; Stine Horskær; Christina Stilling; Frede Donskov
Journal:  Cardiooncology       Date:  2021-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.